| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/21/2007 | CN1915300A Medication of medical broth for treating atonic constipation, and preparation method |
| 02/21/2007 | CN1915296A Medication of medical broth for treating reversed flow of qi type vertigo disease, and preparation method |
| 02/21/2007 | CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic |
| 02/21/2007 | CN1915248A Liandan antiinflammation drop pills, and preparation technique |
| 02/21/2007 | CN1915242A Exterior coating medication for treating ulcer in the oral cavity, and preparation method |
| 02/21/2007 | CN1915241A Medication for pasting on umbilicus to treat atonic constipation, and preparation method |
| 02/21/2007 | CN1915240A Medication for treating ulcer of upper digestive tract |
| 02/21/2007 | CN1915239A Medication for treating gastric ulcer, duodenal ulcer |
| 02/21/2007 | CN1915238A Medicinal composition for improving effect of anti hepatic fibrosis |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1915223A Chewing tablet of compound aluminum magnesium hydroxide, preparation method and method for measuring quality |
| 02/21/2007 | CN1915086A Appetitive stomachic health care food |
| 02/21/2007 | CN1915051A Health care tea for improving function of gstrointestinal tract, and preparation method |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301130C Hepatic calculus dissolving solution |
| 02/21/2007 | CN1301129C Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones |
| 02/21/2007 | CN1301126C Coupling agent for external stone crushing and its preparing method |
| 02/21/2007 | CN1301125C Medicine for treating gastrointestinal tract disease |
| 02/21/2007 | CN1301122C Bone strengthening granule of tortoise plastron and astragalus root |
| 02/21/2007 | CN1301117C Ginseng and aconite granules for treating qi vacuity and yang desertion and its preparation method |
| 02/21/2007 | CN1301108C Metaducine dispersion tablet and its preparation method |
| 02/21/2007 | CN1301096C Cordyceps drip pill used for nourishing lung and kidney and its preparation method |
| 02/21/2007 | CN1301070C Heath-caring product having protecting function for chemical liver injury |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179830 Such as 2-(4-methyl-3-thienylamino)-1H-thieno[3,4-d]imidazole for treatment of repiratory disorders, sleep apnea |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
| 02/20/2007 | US7179492 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof |
| 02/20/2007 | US7179460 Probiotic lactobacillus and bifidobacterium for treatment, prevention and/or reduction of allergenicity, gastrointestinal, cell proliferative and cholesterol disorders |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2218499C Chemokine binding protein and methods of use therefor |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer |
| 02/15/2007 | WO2007018124A1 Agent for enhancing collagen production and utilization of the same |
| 02/15/2007 | WO2007018090A1 Preventive/therapeutic agent for gingival hypertrophy using bupleurum root |
| 02/15/2007 | WO2007017139A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/15/2007 | WO2007016953A1 Composition for reducing alcohol induced liver cancer risk |
| 02/15/2007 | WO2007016952A1 Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer |
| 02/15/2007 | WO2007016951A1 Composition for reducing the risc of alcohol induced pancreatic cancer |
| 02/15/2007 | WO2006122925A3 Oral medicament based on a proton pump inhibitors |
| 02/15/2007 | WO2006108599A3 Ghrelin binding nucleic acids |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/15/2007 | US20070037879 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037878 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/15/2007 | US20070037867 Antihepatitis c virus agent and anti-hiv agent |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells |
| 02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 02/15/2007 | US20070037803 Benzimidazole derivatives |
| 02/15/2007 | US20070037792 Pharmaceutical compositions |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037735 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/15/2007 | US20070037159 Tetrahydrofolate synthetase gene |
| 02/15/2007 | US20070036860 Treatment of allergic conditions |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036774 Liver engrafting cells, assays, and uses thereof |
| 02/15/2007 | US20070036768 Systems and methods for treating patients with processed lipoaspirate cells |
| 02/15/2007 | US20070036734 Therapeutic agent for periodontal disease |
| 02/15/2007 | DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives |
| 02/15/2007 | DE102005037791A1 Verwendung von spezifischen Trifluormethylketonen zur Vorbeugung und Behandlung einer Pankreatitis Use of specific trifluoromethyl ketones for the prevention and treatment of pancreatitis |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2611389A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/14/2007 | EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease |
| 02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
| 02/14/2007 | EP1751096A2 Salt of 4- or 5- aminosalicylic acid |
| 02/14/2007 | EP1750755A1 Methods and formulations for increasing intestinal function |
| 02/14/2007 | EP1750753A1 A composition comprising pyy for the treatment of gastrointestinal disorders |
| 02/14/2007 | EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases |
| 02/14/2007 | EP1515963B1 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1402886B1 Lipolysis accelerator for reducing body weight and medicinal use |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
| 02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1280515B1 Pharmaceutical compositions comprising cannabis |
| 02/14/2007 | EP1267857B1 In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB |
| 02/14/2007 | EP1246639B1 Glp-2 formulations |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | CN1914220A Prodrug comprising 5-aminosalicylate glycoside |
| 02/14/2007 | CN1913911A Physiologically functional drinks and compositions |
| 02/14/2007 | CN1913910A Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof |
| 02/14/2007 | CN1913786A Food and feed supplement and its use |